glucose, (beta-d)-isomer has been researched along with Atherosclerotic Parkinsonism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Lin, F; Liu, J; Lu, D; Shi, J; Wang, G; Wu, Q; Zhang, F | 1 |
| Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Sun, CH; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL; Zhuang, J | 1 |
| An, JP; Dhodary, B; Kim, KS; Lee, CH; Lee, HJ; Lee, JY; Oh, WK; Ryu, YK | 1 |
| Ji, XQ; Jin, DZ; Liu, DZ; Tang, CP; Ye, Y; Zhang, LM; Zhu, J; Zhu, XZ | 1 |
4 other study(ies) available for glucose, (beta-d)-isomer and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity.
Topics: Animals; Dopamine; Glucosides; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Rats; Stilbenes | 2018 |
Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Topics: Animals; Antioxidants; Apoptosis; Female; Glucosides; Male; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phenols; Rats; Rats, Wistar; Wnt Signaling Pathway | 2018 |
Dereplication of Components Coupled with HPLC-qTOF-MS in the Active Fraction of
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavones; Gene Expression Regulation; Glucosides; Humans; Humulus; Magnetic Resonance Spectroscopy; Mice; Monoamine Oxidase; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Plant Extracts; Tandem Mass Spectrometry | 2019 |
Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Benzoates; Binding, Competitive; Bridged-Ring Compounds; Dopamine Agonists; Dopamine Antagonists; Glucosides; Hydroxydopamines; In Vitro Techniques; Male; Membranes; Microinjections; Monoterpenes; Neostriatum; Parkinson Disease, Secondary; Raclopride; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 2007 |